Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 37 | 0 | 0 | 3 | 62 |
| Gross Profit | 37 | N/A | N/A | 3 | 62 |
| Operating Expenses | 907 | 888 | 674 | 518 | 781 |
| Operating Income | -870 | -888 | -674 | -516 | -719 |
| Interest Expense | 1 | 7 | 21 | -10 | 14 |
| Other Income | -1,100 | -1,479 | -943 | -854 | -1,032 |
| Pre-tax Income | -1,971 | -2,375 | -1,638 | -1,360 | -1,765 |
| Net Income Continuous | -1,971 | -2,375 | -1,638 | -1,360 | -1,765 |
| Net Income Discontinuous | N/A | 143 | N/A | 432 | -3 |
| Net Income | $-1,971 | $-2,232 | $-1,638 | $-928 | $-1,768 |
| EPS Basic Total Ops | -2.10 | -2.91 | -1.33 | -0.82 | -2.77 |
| EPS Basic Continuous Ops | -2.10 | -2.83 | -2.00 | -1.66 | -2.16 |
| EPS Basic Discontinuous Ops | N/A | 0.17 | N/A | 0.57 | 0.00 |
| EPS Diluted Total Ops | -2.10 | -2.91 | -1.33 | 5.81 | -2.77 |
| EPS Diluted Continuous Ops | -2.10 | -2.83 | -2.00 | -2.48 | -2.16 |
| EPS Diluted Discontinuous Ops | N/A | 0.17 | N/A | 8.60 | 0.00 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.91 | -1.33 | N/A | -2.77 |
| EBITDA(a) | $-867 | $-886 | $-672 | $-493 | $-648 |